Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMNP $3.28 0.3300 +11.19%
RNN $0.74 0.0300 +4.23%
IDRA $2.45 0.0700 +2.94%
BCRX $11.70 0.3300 +2.90%
MYGN $37.60 0.9200 +2.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ONTY $1.77 -0.1300 -6.84%
GALT $4.76 -0.3300 -6.48%
DNDN $1.03 -0.0700 -6.36%
NWBO $4.78 -0.3100 -6.09%
Kite $33.69 -2.0600 -5.76%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

Colon Cancer Survivors' Obesity and Cancer Risk

(WebMD/HealthDay News) Sept 30, 2014 - Colon cancer patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer, new research suggests.
read article 

Exposure to Dim Light at Night May Make Breast Cancers Resistant to Chemotherapy

(AACR) Sept 30, 2014 - Exposure to dim light at night made breast tumors resistant to the standard breast cancer chemotherapy doxorubicin, according to data presented at the 13th Annual AACR International Conference on Frontiers in Cancer Prevention Research, held Sept. 28–Oct. 1.
read press release 

Many Women Receive Unnecessary Pap Tests

(Center for Advancing Health/HBNS) Sept 30, 2014 - Performing unnecessary Pap tests can result in stress for the patient, increased costs, and inefficient use of both provider and patient time, concludes a new study in the American Journal of Preventive Medicine.
read press release 

Targeted Treatment Could Halt Womb Cancer Growth

(Cancer Research UK) Oct 1, 2014 - A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research* published in the British Journal of Cancer.
read press release 

FDG-PET/CT Shows Promise for Breast Cancer Patients Younger Than 40

(SNMMI) Oct 1, 2014 — Researchers at Memorial Sloan Kettering found that PET/CT imaging of patients younger than 40 who were initially diagnosed with stage I–III breast cancer resulted in change of diagnosis.
read press release 

ASCO Calls for New Action to Address Obesity and Cancer

(ASCO in Action) Oct 1, 2014 - New ASCO policy statement recommends steps to limit the harmful effects of obesity on cancer patients and survivors, slow the rise in obesity-related cancers nationwide.
read article 

Sanofi Posts Positive Results For Drug in Chronic Sinusitis

(Reuters) Sept 30, 2014 - Sanofi and its U.S. partner Regeneron on Tuesday unveiled positive mid-stage trial results for their experimental drug dupilumab in patients with chronic sinusitis with nasal polyps.
read article 

Catalyst Pharma Closer to Unconscionable Price Hike For Rare-Disease Drug

(TheStreet) Sept 30, 2014 - Good news for Catalyst Pharmaceutical Partners Monday is bad news for patients with a rare neuromuscular disease and the U.S. health care system.
read article 

Salix Constipation Treatment Wins FDA Approval

(News & Observer [Raleigh, NC]/.Biz blog) Sept 30, 2014 - Federal regulators on Monday approved Salix Pharmaceuticals drug Relistor for treatment of constipation in patients taking pain medicines.
read article 

Johnson & Johnson to Buy Biotech Company Alios BioPharma

(New York Times/DealBook) Sept 30, 2014 - Johnson & Johnson said on Tuesday that it would pay $1.75 billion in cash for Alios BioPharma, a private biotechnology company that is working on treatments for viral diseases.
read article 

Design Power: Patients Play Researchers in Drug Trials

(Wall Street Journal) Sept 29, 2014 - Scientists regularly sign up patients in clinical trials to test new treatments. Now, they are seeking patients to help them design some of those trials.
read article (paid subscription required) 

What We’re Learning About Drug Company Payments to Doctors

(New York Times/The Upshot) Sept 29, 2014 - On Tuesday, the federal government is expected to release details of payments to doctors by every pharmaceutical and medical device manufacturer in the country.
read article 

New Federal Database Details Medical World’s Financial Links to Drugmakers

(New York Times) Sept 30, 2014 - A federal website that lets patients look up doctor’s payments from drug and medical device makers is expected to go live on Tuesday, a database that will add new depth and details about the medical world’s financial ties to the industry.
read article 

CancerCare® Awarded $1.5 Million Grant From Susan G. Komen®

(CancerCare COPELINK blog) Sept 29, 2014 – CancerCare, the leading national nonprofit organization providing free, professional support services to anyone affected by cancer, has received a $1.5 million grant to assist people diagnosed with breast cancer.
read article 

Breast Cancer Surgeon Joins Henry Ford Hospital

(Henry Ford Health System) Sept 24, 2014 - Breast cancer surgeon Erica N. Proctor, M.D., has joined the Josephine Ford Cancer Institute at Henry Ford Hospital in Detroit.
read press release 

Sylvester Physicians to Investigate Breast Cancer and Depression Connection

(University of Miami Health System) Sept 30, 2014 - Breast cancer patients who suffer from depression may be at an increased risk for metastasis.
read press release 

Call Widens For Medicare CT Lung Cancer Screening Coverage

(Lung Cancer Alliance) Sept 29, 2014 - More than 60 patient advocacy and medical organizations have joined a coalition headed by the Lung Cancer Alliance, the American College of Radiology and The Society of Thoracic Surgeons, in urging Medicare to cover low dose computed tomography (LDCT) screening for beneficiaries at high risk for lung cancer.
read press release 

OncoMed Pharmaceuticals Announces Selection of First Small Molecule Product Candidate Targeting the Wnt Pathway Under Collaboration With Bayer Pharma AG

(Yahoo! Finance) Sept 30, 2014 - OncoMed Pharmaceuticals, Inc. today announced the advancement of the first small molecule Wnt pathway inhibitor under its collaboration with Bayer Pharma AG.
read article 

Pfizer And Kyowa Hakko Kirin to Collaborate on Immuno-Oncology Combination Study

(Pfizer) Sept 29, 2014 - Agreement to combine Kyowa Hakko Kirin’s anti-CCR4 antibody mogamulizumab and Pfizer’s investigational 4-1BB agonist (PF-05082566) in clinical study.
read corporate press release 

GE Healthcare to Collaborate With GlaxoSmithKline on Commercial Oncology Testing

(CNBC) Sept 30, 2014 - GE Healthcare today announced an agreement between its affiliate, Clarient Diagnostic Services, Inc. and GlaxoSmithKline. The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types.
read article 

Cigna Using NCCN Content For Oncology Coverage Policy Development

(NCCN) Sept 30, 2014 - As part of the company’s coverage policy development, Cigna is using the NCCN Guidelines® and the NCCN Compendium® as references in the appropriate choice for the treatment of people with cancer in the United States.
read press release 

Cancer Survivors Face Lasting Financial Struggles Long After Treatment Ends, New Study Reveals

(CNNMoney) Sept 30, 2014 - The majority (62%) of America's middle-income cancer survivors say they were not financially prepared for cancer diagnosis and treatment, according to a new study released by the Washington National Institute for Wellness Solutions (IWS).
read article 

In War on Cancer, Patients at Risk of Becoming Commoditized

(The Hill/Congress Blog) Sept 27, 2014 - Over the past 40 years, the global medical community has made significant strides in the war against cancer.
read article 

Least Costly Alternatives for Drugs in the World of Hematology

(ASH) Sept 23, 2014 - The Medicare Payment Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to take on an issue that could be very important for hematologists and access to drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis.
read article 

Statement From ASH President Linda J. Burns, MD, on Release of Sunshine Act Data

(ASH) Sept 30, 2014 - Today the Centers for Medicare & Medicaid Services (CMS) released a large set of data about the payments physicians and teaching hospitals received from pharmaceutical and medical device companies from August 1 to December 31, 2013.
read press release